Latest News by Industry
CAMBRIDGE, Mass. (AP) _ Seres Therapeutics Inc. (MCRB) on Wednesday reported a third-quarter loss of $60 million, after reporting a profit in the same period a year earlier.
The Cambridge, Massachusetts-based company said it had a loss of 49 cents per share.
The results did not meet Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 45 cents per share.
The drug developer posted revenue of $3.4 million in the period, which also did not meet Street forecasts. Four analysts surveyed by Zacks expected $12.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a MCRB">Zacks stock report on MCRB at https://www.zacks.com/ap/MCRB